{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,21]],"date-time":"2026-10-21T22:29:11Z","timestamp":1792621751706,"version":"4.5.0"},"reference-count":80,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[2025,9,6]],"date-time":"2025-09-06T00:00:00Z","timestamp":1757116800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2025,9,6]],"date-time":"2025-09-06T00:00:00Z","timestamp":1757116800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["32070747"],"award-info":[{"award-number":["32070747"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004829","name":"Department of Science and Technology of Sichuan Province","doi-asserted-by":"publisher","award":["2022NSFC0771"],"award-info":[{"award-number":["2022NSFC0771"]}],"id":[{"id":"10.13039\/501100004829","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100002855","name":"Ministry of Science and Technology of the People's Republic of China","doi-asserted-by":"publisher","award":["2022YFA1103700"],"award-info":[{"award-number":["2022YFA1103700"]}],"id":[{"id":"10.13039\/501100002855","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Cell Death Differ"],"published-print":{"date-parts":[[2026,3]]},"DOI":"10.1038\/s41418-025-01575-8","type":"journal-article","created":{"date-parts":[[2025,9,6]],"date-time":"2025-09-06T02:05:49Z","timestamp":1757124349000},"page":"465-479","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":10,"title":["PRMT5 encourages cell migration and metastasis of tongue squamous cell carcinoma through methylating \u0394Np63\u03b1"],"prefix":"10.1038","volume":"33","author":[{"given":"Shijie","family":"Fan","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wen-juan","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yucheng","family":"Qi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zejiao","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yao-hui","family":"He","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiushuang","family":"Luo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaoyun","family":"Nie","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jia","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jinqi","family":"Ji","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Haoran","family":"Tian","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yang","family":"Cao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ya","family":"Hou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ning","family":"Ji","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2504-5742","authenticated-orcid":false,"given":"Zhi-xiong Jim","family":"Xiao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1958-710X","authenticated-orcid":false,"given":"Xiaobo","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3434-4162","authenticated-orcid":false,"given":"Wen","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7096-6845","authenticated-orcid":false,"given":"Chenghua","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,9,6]]},"reference":[{"key":"1575_CR1","first-page":"209","volume":"71","author":"H Sung","year":"2021","unstructured":"Sung H, Ferlay J, Siegel RL, Laversanne M, Soerjomataram I, Jemal A, et al. Global Cancer Statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin. 2021;71:209\u201349.","journal-title":"CA Cancer J Clin"},{"key":"1575_CR2","doi-asserted-by":"publisher","first-page":"5567","DOI":"10.7314\/APJCP.2013.14.10.5567","volume":"14","author":"SV Krishna Rao","year":"2013","unstructured":"Krishna Rao SV, Mejia G, Roberts-Thomson K, Logan R. Epidemiology of oral cancer in Asia in the past decade-an update (2000-2012). Asian Pac J Cancer Prev. 2013;14:5567\u201377.","journal-title":"Asian Pac J Cancer Prev"},{"key":"1575_CR3","doi-asserted-by":"publisher","first-page":"580","DOI":"10.1038\/bjc.2014.579","volume":"112","author":"V Bagnardi","year":"2015","unstructured":"Bagnardi V, Rota M, Botteri E, Tramacere I, Islami F, Fedirko V, et al. Alcohol consumption and site-specific cancer risk: a comprehensive dose-response meta-analysis. Br J Cancer. 2015;112:580\u201393.","journal-title":"Br J Cancer"},{"key":"1575_CR4","doi-asserted-by":"publisher","first-page":"56","DOI":"10.4103\/ijmr.IJMR_2023_17","volume":"148","author":"S Gupta","year":"2018","unstructured":"Gupta S, Gupta R, Sinha DN, Mehrotra R. Relationship between type of smokeless tobacco & risk of cancer: a systematic review. Indian J Med Res. 2018;148:56\u201376.","journal-title":"Indian J Med Res"},{"key":"1575_CR5","doi-asserted-by":"publisher","first-page":"369","DOI":"10.1161\/CIRCOUTCOMES.108.831552","volume":"2","author":"M Laclaustra","year":"2009","unstructured":"Laclaustra M, Navas-Acien A, Stranges S, Ordovas JM, Guallar E. Serum selenium concentrations and hypertension in the US Population. Circ Cardiovasc Qual Outcomes. 2009;2:369\u201376.","journal-title":"Circ Cardiovasc Qual Outcomes"},{"key":"1575_CR6","doi-asserted-by":"publisher","first-page":"2461","DOI":"10.1007\/s00405-020-06329-5","volume":"278","author":"L Lau","year":"2021","unstructured":"Lau L, Eu D, Loh T, Ahmed Q, Lim CM. Histopathologic prognostic indices in tongue squamous cell carcinoma. Eur Arch Otorhinolaryngol. 2021;278:2461\u201371.","journal-title":"Eur Arch Otorhinolaryngol"},{"key":"1575_CR7","doi-asserted-by":"publisher","first-page":"639","DOI":"10.1002\/jso.23583","volume":"109","author":"S Thiagarajan","year":"2014","unstructured":"Thiagarajan S, Nair S, Nair D, Chaturvedi P, Kane SV, Agarwal JP, et al. Predictors of prognosis for squamous cell carcinoma of oral tongue. J Surg Oncol. 2014;109:639\u201344.","journal-title":"J Surg Oncol"},{"key":"1575_CR8","doi-asserted-by":"publisher","first-page":"31531","DOI":"10.1074\/jbc.274.44.31531","volume":"274","author":"BP Pollack","year":"1999","unstructured":"Pollack BP, Kotenko SV, He W, Izotova LS, Barnoski BL, Pestka S. The human homologue of the yeast proteins Skb1 and Hsl7p interacts with Jak kinases and contains protein methyltransferase activity. J Biol Chem. 1999;274:31531\u201342.","journal-title":"J Biol Chem"},{"key":"1575_CR9","doi-asserted-by":"publisher","first-page":"32971","DOI":"10.1074\/jbc.M105412200","volume":"276","author":"TL Branscombe","year":"2001","unstructured":"Branscombe TL, Frankel A, Lee JH, Cook JR, Yang Z, Pestka S, et al. PRMT5 (Janus kinase-binding protein 1) catalyzes the formation of symmetric dimethylarginine residues in proteins. J Biol Chem. 2001;276:32971\u20136.","journal-title":"J Biol Chem"},{"key":"1575_CR10","doi-asserted-by":"publisher","first-page":"17960","DOI":"10.1073\/pnas.1209814109","volume":"109","author":"S Antonysamy","year":"2012","unstructured":"Antonysamy S, Bonday Z, Campbell RM, Doyle B, Druzina Z, Gheyi T, et al. Crystal structure of the human PRMT5:MEP50 complex. Proc Natl Acad Sci USA. 2012;109:17960\u20135.","journal-title":"Proc Natl Acad Sci USA"},{"key":"1575_CR11","doi-asserted-by":"publisher","DOI":"10.1038\/ncomms9419","volume":"6","author":"D Hu","year":"2015","unstructured":"Hu D, Gur M, Zhou Z, Gamper A, Hung MC, Fujita N, et al. Interplay between arginine methylation and ubiquitylation regulates KLF4-mediated genome stability and carcinogenesis. Nat Commun. 2015;6:8419.","journal-title":"Nat Commun"},{"key":"1575_CR12","doi-asserted-by":"publisher","first-page":"1431","DOI":"10.1038\/ncb1802","volume":"10","author":"M Jansson","year":"2008","unstructured":"Jansson M, Durant ST, Cho EC, Sheahan S, Edelmann M, Kessler B, et al. Arginine methylation regulates the p53 response. Nat Cell Biol. 2008;10:1431\u20139.","journal-title":"Nat Cell Biol"},{"key":"1575_CR13","doi-asserted-by":"publisher","first-page":"235","DOI":"10.1093\/nar\/gkt884","volume":"42","author":"M Girardot","year":"2014","unstructured":"Girardot M, Hirasawa R, Kacem S, Fritsch L, Pontis J, Kota SK, et al. PRMT5-mediated histone H4 arginine-3 symmetrical dimethylation marks chromatin at G + C-rich regions of the mouse genome. Nucleic Acids Res. 2014;42:235\u201348.","journal-title":"Nucleic Acids Res"},{"key":"1575_CR14","doi-asserted-by":"publisher","first-page":"11106","DOI":"10.1093\/nar\/gkx727","volume":"45","author":"M Rengasamy","year":"2017","unstructured":"Rengasamy M, Zhang F, Vashisht A, Song WM, Aguilo F, Sun Y, et al. The PRMT5\/WDR77 complex regulates alternative splicing through ZNF326 in breast cancer. Nucleic Acids Res. 2017;45:11106\u201320.","journal-title":"Nucleic Acids Res"},{"key":"1575_CR15","doi-asserted-by":"publisher","first-page":"12695","DOI":"10.1074\/jbc.M110.103911","volume":"285","author":"J Ren","year":"2010","unstructured":"Ren J, Wang Y, Liang Y, Zhang Y, Bao S, Xu Z. Methylation of ribosomal protein S10 by protein-arginine methyltransferase 5 regulates ribosome biogenesis. J Biol Chem. 2010;285:12695\u2013705.","journal-title":"J Biol Chem"},{"key":"1575_CR16","doi-asserted-by":"publisher","first-page":"1333","DOI":"10.1111\/jcmm.14036","volume":"23","author":"S Zhang","year":"2019","unstructured":"Zhang S, Ma Y, Hu X, Zheng Y, Chen X. Targeting PRMT5\/Akt signalling axis prevents human lung cancer cell growth. J Cell Mol Med. 2019;23:1333\u201342.","journal-title":"J Cell Mol Med"},{"key":"1575_CR17","doi-asserted-by":"publisher","first-page":"2898","DOI":"10.1038\/s41375-019-0489-6","volume":"33","author":"F Zhu","year":"2019","unstructured":"Zhu F, Guo H, Bates PD, Zhang S, Zhang H, Nomie KJ, et al. PRMT5 is upregulated by B-cell receptor signaling and forms a positive-feedback loop with PI3K\/AKT in lymphoma cells. Leukemia. 2019;33:2898\u2013911.","journal-title":"Leukemia"},{"key":"1575_CR18","doi-asserted-by":"publisher","first-page":"174","DOI":"10.1038\/ncb2158","volume":"13","author":"JM Hsu","year":"2011","unstructured":"Hsu JM, Chen CT, Chou CK, Kuo HP, Li LY, Lin CY, et al. Crosstalk between Arg 1175 methylation and Tyr 1173 phosphorylation negatively modulates EGFR-mediated ERK activation. Nat Cell Biol. 2011;13:174\u201381.","journal-title":"Nat Cell Biol"},{"key":"1575_CR19","doi-asserted-by":"publisher","first-page":"509","DOI":"10.1038\/s41573-021-00159-8","volume":"20","author":"Q Wu","year":"2021","unstructured":"Wu Q, Schapira M, Arrowsmith CH, Barsyte-Lovejoy D. Protein arginine methylation: from enigmatic functions to therapeutic targeting. Nat Rev Drug Discov. 2021;20:509\u201330.","journal-title":"Nat Rev Drug Discov"},{"key":"1575_CR20","doi-asserted-by":"publisher","first-page":"9162","DOI":"10.7150\/thno.59605","volume":"11","author":"Y Jiang","year":"2021","unstructured":"Jiang Y, Yuan Y, Chen M, Li S, Bai J, Zhang Y, et al. PRMT5 disruption drives antitumor immunity in cervical cancer by reprogramming T cell-mediated response and regulating PD-L1 expression. Theranostics. 2021;11:9162\u201376.","journal-title":"Theranostics"},{"key":"1575_CR21","doi-asserted-by":"publisher","first-page":"1214","DOI":"10.1126\/science.aad5214","volume":"351","author":"GV Kryukov","year":"2016","unstructured":"Kryukov GV, Wilson FH, Ruth JR, Paulk J, Tsherniak A, Marlow SE, et al. MTAP deletion confers enhanced dependency on the PRMT5 arginine methyltransferase in cancer cells. Science. 2016;351:1214\u20138.","journal-title":"Science"},{"key":"1575_CR22","doi-asserted-by":"publisher","first-page":"314","DOI":"10.1186\/s13046-024-03237-y","volume":"43","author":"Y Guo","year":"2024","unstructured":"Guo Y, Li Y, Zhou Z, Hou L, Liu W, Ren W, et al. Targeting PRMT5 through PROTAC for the treatment of triple-negative breast cancer. J Exp Clin Cancer Res. 2024;43:314.","journal-title":"J Exp Clin Cancer Res"},{"key":"1575_CR23","doi-asserted-by":"publisher","first-page":"288","DOI":"10.1158\/2159-8290.CD-14-0625","volume":"5","author":"Y Li","year":"2015","unstructured":"Li Y, Chitnis N, Nakagawa H, Kita Y, Natsugoe S, Yang Y, et al. PRMT5 is required for lymphomagenesis triggered by multiple oncogenic drivers. Cancer Discov. 2015;5:288\u2013303.","journal-title":"Cancer Discov"},{"key":"1575_CR24","doi-asserted-by":"publisher","first-page":"305","DOI":"10.1016\/S1097-2765(00)80275-0","volume":"2","author":"A Yang","year":"1998","unstructured":"Yang A, Kaghad M, Wang Y, Gillett E, Fleming MD, Dotsch V, et al. p63, a p53 homolog at 3q27-29, encodes multiple products with transactivating, death-inducing, and dominant-negative activities. Mol Cell. 1998;2:305\u201316.","journal-title":"Mol Cell"},{"key":"1575_CR25","doi-asserted-by":"publisher","first-page":"965","DOI":"10.1007\/s00018-017-2666-y","volume":"75","author":"Y Chen","year":"2018","unstructured":"Chen Y, Peng Y, Fan S, Li Y, Xiao ZX, Li C. A double dealing tale of p63: an oncogene or a tumor suppressor. Cell Mol Life Sci. 2018;75:965\u201373.","journal-title":"Cell Mol Life Sci"},{"key":"1575_CR26","doi-asserted-by":"publisher","first-page":"1769","DOI":"10.1016\/S0002-9440(10)64814-6","volume":"157","author":"S Signoretti","year":"2000","unstructured":"Signoretti S, Waltregny D, Dilks J, Isaac B, Lin D, Garraway L, et al. p63 is a prostate basal cell marker and is required for prostate development. Am J Pathol. 2000;157:1769\u201375.","journal-title":"Am J Pathol"},{"key":"1575_CR27","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1186\/s13072-019-0280-y","volume":"12","author":"J Qu","year":"2019","unstructured":"Qu J, Yi G, Zhou H. p63 cooperates with CTCF to modulate chromatin architecture in skin keratinocytes. Epigenetics Chromatin. 2019;12:31.","journal-title":"Epigenetics Chromatin"},{"key":"1575_CR28","doi-asserted-by":"publisher","first-page":"446","DOI":"10.1038\/s41420-023-01716-3","volume":"9","author":"A Smirnov","year":"2023","unstructured":"Smirnov A, Lena AM, Tosetti G, Yang X, Cappello A, Helmer Citterich M, et al. Epigenetic priming of an epithelial enhancer by p63 and CTCF controls expression of a skin-restricted gene XP33. Cell Death Discov. 2023;9:446.","journal-title":"Cell Death Discov"},{"key":"1575_CR29","doi-asserted-by":"publisher","DOI":"10.1038\/s41419-023-06309-7","volume":"14","author":"A Peng","year":"2023","unstructured":"Peng A, Lin X, Yang Q, Sun Y, Chen R, Liu B, et al. DeltaNp63alpha facilitates proliferation and migration, and modulates the chromatin landscape in intrahepatic cholangiocarcinoma cells. Cell Death Dis. 2023;14:777.","journal-title":"Cell Death Dis"},{"key":"1575_CR30","doi-asserted-by":"publisher","first-page":"2325","DOI":"10.1101\/gad.198069.112","volume":"26","author":"CL Gallant-Behm","year":"2012","unstructured":"Gallant-Behm CL, Ramsey MR, Bensard CL, Nojek I, Tran J, Liu M, et al. DeltaNp63alpha represses anti-proliferative genes via H2A.Z deposition. Genes Dev. 2012;26:2325\u201336.","journal-title":"Genes Dev"},{"key":"1575_CR31","first-page":"49","volume":"62","author":"N Thurfjell","year":"2005","unstructured":"Thurfjell N, Coates PJ, Boldrup L, Lindgren B, Backlund B, Uusitalo T, et al. Function and importance of p63 in normal oral mucosa and squamous cell carcinoma of the head and neck. Adv Otorhinolaryngol. 2005;62:49\u201357.","journal-title":"Adv Otorhinolaryngol"},{"key":"1575_CR32","doi-asserted-by":"publisher","first-page":"212","DOI":"10.1038\/onc.2012.564","volume":"33","author":"J Bergholz","year":"2014","unstructured":"Bergholz J, Zhang Y, Wu J, Meng L, Walsh EM, Rai A, et al. DeltaNp63alpha regulates Erk signaling via MKP3 to inhibit cancer metastasis. Oncogene. 2014;33:212\u201324.","journal-title":"Oncogene"},{"key":"1575_CR33","doi-asserted-by":"publisher","DOI":"10.1038\/cddis.2014.239","volume":"5","author":"J Wu","year":"2014","unstructured":"Wu J, Liang S, Bergholz J, He H, Walsh EM, Zhang Y, et al. DeltaNp63alpha activates CD82 metastasis suppressor to inhibit cancer cell invasion. Cell Death Dis. 2014;5:e1280.","journal-title":"Cell Death Dis"},{"key":"1575_CR34","doi-asserted-by":"publisher","first-page":"E3964","DOI":"10.1073\/pnas.1617816114","volume":"114","author":"L Hu","year":"2017","unstructured":"Hu L, Liang S, Chen H, Lv T, Wu J, Chen D, et al. DeltaNp63alpha is a common inhibitory target in oncogenic PI3K\/Ras\/Her2-induced cell motility and tumor metastasis. Proc Natl Acad Sci USA. 2017;114:E3964\u2013E73.","journal-title":"Proc Natl Acad Sci USA"},{"key":"1575_CR35","doi-asserted-by":"publisher","first-page":"1128","DOI":"10.1016\/j.febslet.2012.03.021","volume":"586","author":"YS Chae","year":"2012","unstructured":"Chae YS, Kim H, Kim D, Lee H, Lee HO. Cell density-dependent acetylation of DeltaNp63alpha is associated with p53-dependent cell cycle arrest. FEBS Lett. 2012;586:1128\u201334.","journal-title":"FEBS Lett"},{"key":"1575_CR36","doi-asserted-by":"publisher","first-page":"3207","DOI":"10.4161\/15384101.2014.951285","volume":"13","author":"S Melino","year":"2014","unstructured":"Melino S, Bellomaria A, Nepravishta R, Paci M, Melino G. p63 threonine phosphorylation signals the interaction with the WW domain of the E3 ligase Itch. Cell Cycle. 2014;13:3207\u201317.","journal-title":"Cell Cycle"},{"key":"1575_CR37","doi-asserted-by":"crossref","unstructured":"Armstrong SR, Wu H, Wang B, Abuetabh Y, Sergi C, Leng RP. The regulation of tumor suppressor p63 by the ubiquitin-proteasome system. Int J Mol Sci. 2016;17: 2041.","DOI":"10.3390\/ijms17122041"},{"key":"1575_CR38","doi-asserted-by":"crossref","unstructured":"Chen H, Hu K, Xie Y, Qi Y, Li W, He Y, et al. CDK1 promotes epithelial-mesenchymal transition and migration of head and neck squamous carcinoma cells by repressing \u2206Np63alpha-mediated transcriptional regulation. Int J Mol Sci. 2022;23:7385.","DOI":"10.3390\/ijms23137385"},{"key":"1575_CR39","doi-asserted-by":"publisher","first-page":"2334","DOI":"10.1002\/1873-3468.13104","volume":"592","author":"H He","year":"2018","unstructured":"He H, Peng Y, Fan S, Chen Y, Zheng X, Li C. Cullin3\/KCTD5 induces monoubiquitination of DeltaNp63alpha and impairs its activity. FEBS Lett. 2018;592:2334\u201340.","journal-title":"FEBS Lett"},{"key":"1575_CR40","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-018-28002-y","volume":"8","author":"SV Gerhart","year":"2018","unstructured":"Gerhart SV, Kellner WA, Thompson C, Pappalardi MB, Zhang XP, Montes de Oca R, et al. Activation of the p53-MDM4 regulatory axis defines the anti-tumour response to PRMT5 inhibition through its role in regulating cellular splicing. Sci Rep. 2018;8:9711.","journal-title":"Sci Rep"},{"key":"1575_CR41","doi-asserted-by":"publisher","DOI":"10.1038\/s41419-020-03064-x","volume":"11","author":"N Wang","year":"2020","unstructured":"Wang N, Yan H, Wu D, Zhao Z, Chen X, Long Q, et al. PRMT5\/Wnt4 axis promotes lymph-node metastasis and proliferation of laryngeal carcinoma. Cell Death Dis. 2020;11:864.","journal-title":"Cell Death Dis"},{"key":"1575_CR42","doi-asserted-by":"publisher","first-page":"2931","DOI":"10.1038\/s41418-021-00793-0","volume":"28","author":"X Wang","year":"2021","unstructured":"Wang X, Qiu T, Wu Y, Yang C, Li Y, Du G, et al. Arginine methyltransferase PRMT5 methylates and stabilizes KLF5 via decreasing its phosphorylation and ubiquitination to promote basal-like breast cancer. Cell Death Differ. 2021;28:2931\u201345.","journal-title":"Cell Death Differ"},{"key":"1575_CR43","doi-asserted-by":"publisher","DOI":"10.1155\/2021\/6149558","volume":"2021","author":"Y Ai","year":"2021","unstructured":"Ai Y, Liu S, Luo H, Wu S, Wei H, Tang Z, et al. METTL3 intensifies the progress of oral squamous cell carcinoma via modulating the m6A amount of PRMT5 and PD-L1. J Immunol Res. 2021;2021:6149558.","journal-title":"J Immunol Res"},{"key":"1575_CR44","doi-asserted-by":"publisher","first-page":"3789","DOI":"10.3390\/cancers16223789","volume":"16","author":"H Liang","year":"2024","unstructured":"Liang H, Fisher ML, Wu C, Ballon C, Sun X, Mills AA. PRMT5\/WDR77 enhances the proliferation of squamous cell carcinoma via the DeltaNp63alpha-p21 Axis. Cancers. 2024;16:3789.","journal-title":"Cancers"},{"key":"1575_CR45","doi-asserted-by":"publisher","DOI":"10.1186\/s12964-019-0344-4","volume":"17","author":"Y Qin","year":"2019","unstructured":"Qin Y, Hu Q, Xu J, Ji S, Dai W, Liu W, et al. PRMT5 enhances tumorigenicity and glycolysis in pancreatic cancer via the FBW7\/cMyc axis. Cell Commun Signal. 2019;17:30.","journal-title":"Cell Commun Signal"},{"key":"1575_CR46","doi-asserted-by":"publisher","first-page":"2423","DOI":"10.1242\/jcs.061010","volume":"123","author":"F Galli","year":"2010","unstructured":"Galli F, Rossi M, D\u2019Alessandra Y, De Simone M, Lopardo T, Haupt Y, et al. MDM2 and Fbw7 cooperate to induce p63 protein degradation following DNA damage and cell differentiation. J Cell Sci. 2010;123:2423\u201333.","journal-title":"J Cell Sci"},{"key":"1575_CR47","doi-asserted-by":"publisher","DOI":"10.1186\/s12885-021-07866-w","volume":"21","author":"ES Alshammari","year":"2021","unstructured":"Alshammari ES, Aljagthmi AA, Stacy AJ, Bottomley M, Shamma HN, Kadakia MP, et al. ERK3 is transcriptionally upregulated by \u2206Np63alpha and mediates the role of \u2206Np63alpha in suppressing cell migration in non-melanoma skin cancers. BMC Cancer. 2021;21:155.","journal-title":"BMC Cancer"},{"key":"1575_CR48","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-022-28202-1","volume":"13","author":"M Napoli","year":"2022","unstructured":"Napoli M, Wu SJ, Gore BL, Abbas HA, Lee K, Checker R, et al. DeltaNp63 regulates a common landscape of enhancer associated genes in non-small cell lung cancer. Nat Commun. 2022;13:614.","journal-title":"Nat Commun"},{"key":"1575_CR49","doi-asserted-by":"publisher","first-page":"863","DOI":"10.15252\/embr.201439941","volume":"16","author":"EN Kouwenhoven","year":"2015","unstructured":"Kouwenhoven EN, Oti M, Niehues H, van Heeringen SJ, Schalkwijk J, Stunnenberg HG, et al. Transcription factor p63 bookmarks and regulates dynamic enhancers during epidermal differentiation. EMBO Rep. 2015;16:863\u201378.","journal-title":"EMBO Rep"},{"key":"1575_CR50","doi-asserted-by":"publisher","DOI":"10.1186\/s12964-024-01794-5","volume":"22","author":"E Vasilaki","year":"2024","unstructured":"Vasilaki E, Bai Y, Ali MM, Sundqvist A, Moustakas A, Heldin CH. DeltaNp63 bookmarks and creates an accessible epigenetic environment for TGFbeta-induced cancer cell stemness and invasiveness. Cell Commun Signal. 2024;22:411.","journal-title":"Cell Commun Signal"},{"key":"1575_CR51","doi-asserted-by":"publisher","first-page":"4325","DOI":"10.1007\/s00018-020-03539-2","volume":"77","author":"M Yi","year":"2020","unstructured":"Yi M, Tan Y, Wang L, Cai J, Li X, Zeng Z, et al. TP63 links chromatin remodeling and enhancer reprogramming to epidermal differentiation and squamous cell carcinoma development. Cell Mol Life Sci. 2020;77:4325\u201346.","journal-title":"Cell Mol Life Sci"},{"key":"1575_CR52","doi-asserted-by":"publisher","first-page":"W427","DOI":"10.1093\/nar\/gkad303","volume":"51","author":"H Tian","year":"2023","unstructured":"Tian H, Xiao S, Jiang X, Tao P. PASSer: fast and accurate prediction of protein allosteric sites. Nucleic Acids Res. 2023;51:W427\u2013W31.","journal-title":"Nucleic Acids Res"},{"key":"1575_CR53","first-page":"7113","volume":"63","author":"PP Massion","year":"2003","unstructured":"Massion PP, Taflan PM, Jamshedur Rahman SM, Yildiz P, Shyr Y, Edgerton ME, et al. Significance of p63 amplification and overexpression in lung cancer development and prognosis. Cancer Res. 2003;63:7113\u201321.","journal-title":"Cancer Res"},{"key":"1575_CR54","doi-asserted-by":"publisher","first-page":"5462","DOI":"10.1073\/pnas.97.10.5462","volume":"97","author":"K Hibi","year":"2000","unstructured":"Hibi K, Trink B, Patturajan M, Westra WH, Caballero OL, Hill DE, et al. AIS is an oncogene amplified in squamous cell carcinoma. Proc Natl Acad Sci USA. 2000;97:5462\u20137.","journal-title":"Proc Natl Acad Sci USA"},{"key":"1575_CR55","doi-asserted-by":"publisher","first-page":"2041","DOI":"10.1007\/s00018-015-1847-9","volume":"72","author":"N Stopa","year":"2015","unstructured":"Stopa N, Krebs JE, Shechter D. The PRMT5 arginine methyltransferase: many roles in development, cancer and beyond. Cell Mol Life Sci. 2015;72:2041\u201359.","journal-title":"Cell Mol Life Sci"},{"key":"1575_CR56","doi-asserted-by":"publisher","first-page":"36705","DOI":"10.18632\/oncotarget.26404","volume":"9","author":"H Shailesh","year":"2018","unstructured":"Shailesh H, Zakaria ZZ, Baiocchi R, Sif S. Protein arginine methyltransferase 5 (PRMT5) dysregulation in cancer. Oncotarget. 2018;9:36705\u201318.","journal-title":"Oncotarget"},{"key":"1575_CR57","doi-asserted-by":"publisher","first-page":"617","DOI":"10.1016\/j.neo.2020.09.004","volume":"22","author":"Z Fan","year":"2020","unstructured":"Fan Z, He L, Li M, Cao R, Deng M, Ping F, et al. Targeting methyltransferase PRMT5 retards the carcinogenesis and metastasis of HNSCC via epigenetically inhibiting Twist1 transcription. Neoplasia. 2020;22:617\u201329.","journal-title":"Neoplasia"},{"key":"1575_CR58","doi-asserted-by":"publisher","first-page":"3224","DOI":"10.1016\/j.celrep.2018.08.058","volume":"24","author":"CG Abraham","year":"2018","unstructured":"Abraham CG, Ludwig MP, Andrysik Z, Pandey A, Joshi M, Galbraith MD, et al. DeltaNp63alpha suppresses TGFB2 expression and RHOA activity to drive cell proliferation in squamous cell carcinomas. Cell Rep. 2018;24:3224\u201336.","journal-title":"Cell Rep"},{"key":"1575_CR59","doi-asserted-by":"publisher","first-page":"3688","DOI":"10.1158\/0008-5472.CAN-10-3445","volume":"71","author":"X Yang","year":"2011","unstructured":"Yang X, Lu H, Yan B, Romano RA, Bian Y, Friedman J, et al. DeltaNp63 versatilely regulates a Broad NF-kappaB gene program and promotes squamous epithelial proliferation, migration, and inflammation. Cancer Res. 2011;71:3688\u2013700.","journal-title":"Cancer Res"},{"key":"1575_CR60","doi-asserted-by":"publisher","first-page":"3742","DOI":"10.7150\/thno.53023","volume":"11","author":"L Yang","year":"2021","unstructured":"Yang L, Ma DW, Cao YP, Li DZ, Zhou X, Feng JF, et al. PRMT5 functionally associates with EZH2 to promote colorectal cancer progression through epigenetically repressing CDKN2B expression. Theranostics. 2021;11:3742\u201359.","journal-title":"Theranostics"},{"key":"1575_CR61","doi-asserted-by":"publisher","DOI":"10.1002\/advs.202400160","volume":"11","author":"X Lu","year":"2024","unstructured":"Lu X, Zhang C, Zhu L, Wang S, Zeng L, Zhong W, et al. TBL2 promotes tumorigenesis via PRMT5\/WDR77-mediated AKT activation in breast cancer. Adv Sci. 2024;11:e2400160.","journal-title":"Adv Sci"},{"key":"1575_CR62","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-023-36410-6","volume":"14","author":"S Goruppi","year":"2023","unstructured":"Goruppi S, Clocchiatti A, Bottoni G, Di Cicco E, Ma M, Tassone B, et al. The ULK3 kinase is a determinant of keratinocyte self-renewal and tumorigenesis targeting the arginine methylome. Nat Commun. 2023;14:887.","journal-title":"Nat Commun"},{"key":"1575_CR63","doi-asserted-by":"publisher","DOI":"10.1002\/advs.202003047","volume":"8","author":"C Cai","year":"2021","unstructured":"Cai C, Gu S, Yu Y, Zhu Y, Zhang H, Yuan B, et al. PRMT5 enables robust STAT3 activation via arginine symmetric dimethylation of SMAD7. Adv Sci. 2021;8:2003047.","journal-title":"Adv Sci"},{"key":"1575_CR64","doi-asserted-by":"publisher","DOI":"10.1126\/sciadv.adq0479","volume":"10","author":"Y Zhang","year":"2024","unstructured":"Zhang Y, Karagiannis D, Liu H, Lin M, Fang Y, Jiang M, et al. Epigenetic regulation of p63 blocks squamous-to-neuroendocrine transdifferentiation in esophageal development and malignancy. Sci Adv. 2024;10:eadq0479.","journal-title":"Sci Adv"},{"key":"1575_CR65","doi-asserted-by":"publisher","DOI":"10.1126\/scitranslmed.adi7244","volume":"15","author":"G Wu","year":"2023","unstructured":"Wu G, Yoshida N, Liu J, Zhang X, Xiong Y, Heavican-Foral TB, et al. TP63 fusions drive multicomplex enhancer rewiring, lymphomagenesis, and EZH2 dependence. Sci Transl Med. 2023;15:eadi7244.","journal-title":"Sci Transl Med"},{"key":"1575_CR66","doi-asserted-by":"publisher","first-page":"933","DOI":"10.1038\/nature06166","volume":"449","author":"E Guccione","year":"2007","unstructured":"Guccione E, Bassi C, Casadio F, Martinato F, Cesaroni M, Schuchlautz H, et al. Methylation of histone H3R2 by PRMT6 and H3K4 by an MLL complex are mutually exclusive. Nature. 2007;449:933\u20137.","journal-title":"Nature"},{"key":"1575_CR67","doi-asserted-by":"publisher","first-page":"100","DOI":"10.1016\/j.ccell.2019.05.014","volume":"36","author":"A Fedoriw","year":"2019","unstructured":"Fedoriw A, Rajapurkar SR, O\u2019Brien S, Gerhart SV, Mitchell LH, Adams ND, et al. Anti-tumor activity of the Type I PRMT inhibitor, GSK3368715, synergizes with PRMT5 inhibition through MTAP loss. Cancer Cell. 2019;36:100\u201314.e25.","journal-title":"Cancer Cell"},{"key":"1575_CR68","doi-asserted-by":"publisher","first-page":"136","DOI":"10.1038\/nsmb.2209","volume":"19","author":"V Migliori","year":"2012","unstructured":"Migliori V, Muller J, Phalke S, Low D, Bezzi M, Mok WC, et al. Symmetric dimethylation of H3R2 is a newly identified histone mark that supports euchromatin maintenance. Nat Struct Mol Biol. 2012;19:136\u201344.","journal-title":"Nat Struct Mol Biol"},{"key":"1575_CR69","doi-asserted-by":"publisher","first-page":"jcs217406","DOI":"10.1242\/jcs.217406","volume":"131","author":"Q Li","year":"2018","unstructured":"Li Q, Jiao J, Li H, Wan H, Zheng C, Cai J, et al. Histone arginine methylation by Prmt5 is required for lung branching morphogenesis through repression of BMP signaling. J Cell Sci. 2018;131:jcs217406.","journal-title":"J Cell Sci"},{"key":"1575_CR70","doi-asserted-by":"publisher","first-page":"566","DOI":"10.1016\/j.cell.2011.01.013","volume":"144","author":"GB Deutsch","year":"2011","unstructured":"Deutsch GB, Zielonka EM, Coutandin D, Weber TA, Schafer B, Hannewald J, et al. DNA damage in oocytes induces a switch of the quality control factor TAp63alpha from dimer to tetramer. Cell. 2011;144:566\u201376.","journal-title":"Cell"},{"key":"1575_CR71","doi-asserted-by":"publisher","first-page":"6456","DOI":"10.1073\/pnas.1013657108","volume":"108","author":"C Chen","year":"2011","unstructured":"Chen C, Gorlatova N, Kelman Z, Herzberg O. Structures of p63 DNA binding domain in complexes with half-site and with spacer-containing full response elements. Proc Natl Acad Sci USA. 2011;108:6456\u201361.","journal-title":"Proc Natl Acad Sci USA"},{"key":"1575_CR72","doi-asserted-by":"publisher","first-page":"58","DOI":"10.36401\/JIPO-22-1","volume":"5","author":"K Feustel","year":"2022","unstructured":"Feustel K, Falchook GS. Protein arginine methyltransferase 5 (PRMT5) inhibitors in oncology clinical trials: a review. J Immunother Precis Oncol. 2022;5:58\u201367.","journal-title":"J Immunother Precis Oncol"},{"key":"1575_CR73","doi-asserted-by":"publisher","first-page":"2177","DOI":"10.1016\/j.ymthe.2020.06.024","volume":"28","author":"L Liu","year":"2020","unstructured":"Liu L, Wu Y, Li Q, Liang J, He Q, Zhao L, et al. METTL3 promotes tumorigenesis and metastasis through BMI1 m(6)A methylation in oral squamous cell carcinoma. Mol Ther. 2020;28:2177\u201390.","journal-title":"Mol Ther"},{"key":"1575_CR74","doi-asserted-by":"publisher","first-page":"3264","DOI":"10.1038\/s41596-020-0373-x","volume":"15","author":"HS Kaya-Okur","year":"2020","unstructured":"Kaya-Okur HS, Janssens DH, Henikoff JG, Ahmad K, Henikoff S. Efficient low-cost chromatin profiling with CUT&Tag. Nat Protoc. 2020;15:3264\u201383.","journal-title":"Nat Protoc"},{"key":"1575_CR75","doi-asserted-by":"publisher","first-page":"42","DOI":"10.1186\/s13072-019-0287-4","volume":"12","author":"MP Meers","year":"2019","unstructured":"Meers MP, Tenenbaum D, Henikoff S. Peak calling by sparse enrichment analysis for CUT&RUN chromatin profiling. Epigenetics Chromatin. 2019;12:42.","journal-title":"Epigenetics Chromatin"},{"key":"1575_CR76","doi-asserted-by":"publisher","DOI":"10.1186\/gb-2012-13-3-r16","volume":"13","author":"Z Shao","year":"2012","unstructured":"Shao Z, Zhang Y, Yuan GC, Orkin SH, Waxman DJ. MAnorm: a robust model for quantitative comparison of ChIP-Seq data sets. Genome Biol. 2012;13:R16.","journal-title":"Genome Biol"},{"key":"1575_CR77","doi-asserted-by":"publisher","DOI":"10.1186\/1471-2164-15-284","volume":"15","author":"L Shen","year":"2014","unstructured":"Shen L, Shao N, Liu X, Nestler E. ngs.plot: quick mining and visualization of next-generation sequencing data by integrating genomic databases. BMC Genomics. 2014;15:284.","journal-title":"BMC Genomics"},{"key":"1575_CR78","doi-asserted-by":"publisher","DOI":"10.1186\/s13059-014-0550-8","volume":"15","author":"MI Love","year":"2014","unstructured":"Love MI, Huber W, Anders S. Moderated estimation of fold change and dispersion for RNA-seq data with DESeq2. Genome Biol. 2014;15:550.","journal-title":"Genome Biol"},{"key":"1575_CR79","doi-asserted-by":"publisher","first-page":"3451","DOI":"10.7150\/thno.39241","volume":"10","author":"BL Peng","year":"2020","unstructured":"Peng BL, Li WJ, Ding JC, He YH, Ran T, Xie BL, et al. A hypermethylation strategy utilized by enhancer-bound CARM1 to promote estrogen receptor alpha-dependent transcriptional activation and breast carcinogenesis. Theranostics. 2020;10:3451\u201373.","journal-title":"Theranostics"},{"key":"1575_CR80","doi-asserted-by":"publisher","first-page":"3604","DOI":"10.3390\/ijms24043604","volume":"24","author":"Y Tsuji","year":"2023","unstructured":"Tsuji Y. Optimization of biotinylated RNA or DNA pull-down assays for detection of binding proteins: examples of IRP1, IRP2, HuR, AUF1, and Nrf2. Int J Mol Sci. 2023;24:3604.","journal-title":"Int J Mol Sci"}],"container-title":["Cell Death & Differentiation"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41418-025-01575-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41418-025-01575-8","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41418-025-01575-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,3,30]],"date-time":"2026-03-30T11:02:47Z","timestamp":1774868567000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41418-025-01575-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,9,6]]},"references-count":80,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2026,3]]}},"alternative-id":["1575"],"URL":"https:\/\/doi.org\/10.1038\/s41418-025-01575-8","relation":{},"ISSN":["1350-9047","1476-5403"],"issn-type":[{"value":"1350-9047","type":"print"},{"value":"1476-5403","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,9,6]]},"assertion":[{"value":"8 February 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"1 August 2025","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"28 August 2025","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"6 September 2025","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"Animal experiments in this study were performed in accordance with the institutional ethical guidelines and were approved by the Medical Ethics Committee of Sichuan University, China.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval"}}]}}